Answers are grounded in this paper and cite their sources.
Amiodarone and dronedarone exert part of their cardiac effects by acting as thyroid hormone receptor antagonists, inducing a local hypothyroid-like phenotype that alters cardiac gene expression.
This review evaluates the hypothesis that the cardiac effects of amiodarone can be explained-at least partly-by the induction of a local 'hypothyroid-like condition' in the heart. Evidence supporting the hypothesis comprises the observation that amiodarone exerts an inhibitory effect on the binding of T3 to thyroid hormone receptors (TR) alpha-1 and beta-1 in vitro, and on the expression of particular T3-dependent genes in vivo. In the heart, amiodarone decreases heart rate and alpha myosin heavy chain expression (mediated via TR alpha-1), and increases sarcoplasmic reticulum calcium-activated ATPase and beta myosin heavy chain expression (mediated via TR beta-1). Recent data show a significant similarity in expression profiles of 8,435 genes in the heart of hypothyroid and amiodarone-treated animals, although similarities do not always exist in transcripts of ion channel genes. Induction of a hypothyroid cardiac phenotype by amiodarone may be advantageous by decreasing energy demands and increasing energy availability.
No takes yet. Share an insight, caveat, or question.
Wilmar M. Wiersinga (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: